How often should a young, healthy woman be screened for cervical cancer? The question sounds straightforward, but it has opened a genuine rift among specialists, as a new feature in the Annals of Internal Medicine makes clear. In the piece, a primary care physician and an obstetrician-gynecologist debate the best approach for a healthy 26-year-old patient, each drawing on different guidelines, different evidence and different readings of the same data.
At the heart of the disagreement lies a tension familiar across modern medicine: screening saves lives by catching disease early, yet too much testing can trigger unnecessary procedures, anxiety and cost. Cervical cancer screening has evolved rapidly, with updated recommendations stretching intervals between tests and incorporating new technologies. For a woman in her mid-twenties, the choice between an HPV test, a Pap smear, or a combination may hinge on factors that guidelines struggle to capture. The debate is a reminder that even routine decisions often rest on judgment as much as on rules.
